Latest news
Alebund’s AP301 NDA Accepted for Review by China’s NMPA - Macau BusinessMacau Business · Sat, 08 Aug 2026 09:07:49 GMTChina accepts NDA for Alebund's phosphate binder AP301 after Phase III success - AllSciAllSci · Fri, 07 Aug 2026 16:31:47 GMTExclusive BAC Article: Sagimet Biosciences; China NDA Acceptance Denifanstat For Acne, 2nd Half 2026 U.S. Study Initiation, MASH Drug Combination, And Catalysts (NASDAQ:SGMT) - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 18:15:38 GMTHUTCHMED Reports 2026 Interim Results - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 11:00:00 GMT